Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M249Revenue $M1.1Net Margin (%)-924.0Z-Score-31.1
Enterprise Value $M271EPS $-0.4Operating Margin %-785.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-924.0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.5Cash flow > EarningsY
Price/Sales55.35-y EBITDA Growth Rate %71.2Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-129.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M151ROI % (ttm)-168.4Gross Margin Increase y-yN

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

NAVB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0853.7view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0361.17view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.3622.06view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.4316.08view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.3423.88view
Cope Frederick OSVP 2014-03-10Sell15,000$1.96-15.31view
LARSON BRENT LEVP, CFO, Treas & Secy 2014-03-10Sell41,500$1.96-15.31view
PYKETT MARK JEROMECEO 2014-03-10Sell120,000$1.96-15.31view
FORD BRENDAN ADirector 2013-11-08Buy20,000$1.4514.48view
LARSON BRENT LEVP, CFO, Treas & Secy 2013-11-08Buy5,000$1.3919.42view

Press Releases about NAVB :

    Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 15 2013 

    More From Other Websites
    Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Appoints Leading Experts to... Feb 27 2015
    Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Appoints Leading Experts to... Feb 27 2015
    Navidea Biopharmaceuticals to Announce Fourth Quarter and Year-End 2014 Financial Results on March... Feb 26 2015
    Navidea Biopharmaceuticals to Announce Fourth Quarter and Year-End 2014 Financial Results on March... Feb 26 2015
    Lymphoseek® Data Presented in European Medical Conference Reinforces Clinical Value in Head & Neck... Feb 18 2015
    Lymphoseek® Data Presented in European Medical Conference Reinforces Clinical Value in Head & Neck... Feb 18 2015
    Lymphoseek® Results from Phase 3 Clinical Trial in Oral Cavity Cancer of the Head and Neck... Feb 17 2015
    Lymphoseek® Results from Phase 3 Clinical Trial in Oral Cavity Cancer of the Head and Neck... Feb 17 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Feb 09 2015
    Achillion Soars on 6 Week HCV Cure When Used with Gilead's Sofosbuvir - Stocks in the News Feb 09 2015
    Navidea Reports Preliminary 2014 Revenue; Provides Update on New Commercial Strategy Feb 09 2015
    Navidea to Report Preliminary 2014 Revenue and Present at BIO CEO & Investor Conference February 9 Feb 02 2015
    Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients Published in Annals of... Jan 29 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 26 2015
    Navidea’s Macrophage Therapeutics Unit Announces Plan for $2.5 Million Financing Jan 21 2015
    Navidea Biopharmaceuticals to Present at Biotech Showcase 2015 Jan 06 2015
    Navidea Biopharmaceuticals to Present at Biotech Showcase 2015 Jan 06 2015
    Navidea Strengthens Leadership Team to Accelerate Lymphoseek® Growth Jan 05 2015
    Navidea Strengthens Leadership Team to Accelerate Lymphoseek® Growth Jan 05 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 17 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK